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Abstract. The extracellular matrix molecule tenascin
has been implicated in neuron-glia recognition in the
developing central and peripheral nervous system and
in regeneration. In this study, its role in Bergmann
glial process-mediated neuronal migration was assayed
in vitro using tissue explants of the early postnatal
mouse cerebellar cortex. Of the five mAbs reacting
with nonoverlapping epitopes on tenascin, mAbs Jl/
tnl, Jl/tn4, and Jl/tn5, but not mAbs Jl/tn2 and Jl/tn3
inhibited granule cell migration. Localization of the
immunoreactive domains by EM of rotary shadowed
tenascin molecules revealed that the mAbs Jl/tn4 and
Jl/tn5, like the previously described Jl/tnl antibody,
bound between the third and fifth fibronectin type III
homologous repeats and mAb Jl/tn3 bound between the
third and fifth EGF-like repeats. mAb Jl/tn2 had previ-
ously been found to react between fibronectin type III
N
EURONAL migration is an important morphogenetic
feature in the developing nervous system (Purves
and Lichtman 1985 Jacobson 1991 . The exqui-
site specificity of this process has been studied in the devel-
oping mammalian cerebellar cortex, because it is a relatively
simply organized structure ofthe central nervous system and
because it contains few and identifiable neuronal and glial
cell types arranged in simple geometric arrays (Rakic, 1971;
Altman, 1982) . In rodents, much of cerebellar histogenesis,
including neuronal migration, takes place postnatally, ren-
dering theseprocesses more easily amenableto experimental
manipulation (Muleand Sidman, 1961; Fujita, 1967). Thus,
the migration of young postmitotic granule cells from the
external to the internal granular layer has been studied in de-
tail, since it exemplifies a general principle in neuron-glia
interaction, in which migrating neurons are guided by the
radial processes of glial cells (Rakic, 1971; Hatten et al .,
1984).
To characterize the molecular mechanisms involved in
cerebellar morphogenesis, mono- and polyclonal antibodies
reacting with particular cell surface and extracellular matrix
components have been used in in vitro assay systems to
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homologous repeats 10 and 11 of the mouse molecule
(Luchter, A., L. Vaughan, A . Kaplony, A. Prochiantz,
M . Schachner, and A. Faissner. 1991. J. Cell Biol.
113:1159-1171). When postnatal granule cell neurons
were cultured on tenascin adsorbed to polyornithine,
both the percentage of neurite-bearing cells and the
length of outgrowing neurites were increased when
compared to neurons growing on polyornithine alone.
This neurite outgrowth promoting effect of tenascin
was abolished only by mAb Jl/tn2 or tenascin added
to the culture medium in soluble form. The other anti-
bodies did not modify the stimulatory or inhibitory
effects of the molecule. These observations indicate
that tenascin influences neurite outgrowth and migra-
tion of cerebellar granule cells by different domains in
the fibronectin type III homologous repeats.
modify particular aspects of neuronal migration. In such
studies it could be shown that the neural recognition mole-
cule Ll and its structurally related form in chicken, Ng-
CAM (Burgoon et al., 1991), are implicated in cerebellar
granule cell migration, possibly by influencing the fascicula-
tion of axons (Lindner et al., 1983, 1985; Fischer et al.,
1986; Chuong et al., 1987; Persohn and Schachner, 1987).
In addition to LI, the adhesion molecule on glia (AMOG)-a
homologue of the ß-subunit of the Na/KATPase (Antonicek
et al ., 1987; Gloor et al., 1990), a neural lectin and one of
its ligands (Lehmann et al ., 1990), the neural proteoglycan
astrochondrin (Streit, A., C. Nolte, T. Rásonyi, M. Schach-
ner, manuscript submitted for publication), the tissue plas-
minogen-activator/plasmin system (Muonen et al., 1982),
and a protease inhibitor of the nexin family (Lindner et al.,
1986) have all been implicated in granule cell migration in
vitro. Two glia-derived extracellular matrix glycoproteins,
thrombospondin and tenascin (see Sanes, 1989, for review),
have also been shown to influence neuronal migration since
antibodies to thrombospondin (Lawler, 1986)and cytotactin
(Grumet et al., 1985)-which is related to Jl/tenascin (Kruse
et al., 1985, Faissner et al., 1988), tenascin (Chiquet-Ehris-
1475mann et al., 1986), hexabrachion (Erickson and Inglesias,
1984), and glial-mesenchymal extracellular matrix (GMEM)
protein (Bourdon et al ., 1983)-inhibit granule cell migra-
tion in vitro (Chuong et al., 1987, O'Shea et al., 1990) .
The tenascin glycoproteins are extracellular matrix mole-
cules with a cysteine-rich amino terminal domain followed by
13.5 EGF type repeats in chicken and 14.5 EGF type repeats
in mouse and human (Spring et al., 1989; Jones et al., 1989;
Nies et al., 1991; Siri et al., 1991; Weller et al., 1991), eight
fibronectin type III homologous repeats and a fibrinogen ß
and y homologous domain at the carboxy-terminal end. An
increasing number of isoforms have been found, which ap-
pear to be generated by insertion ofadditional, alternatively
spliced fibronectin type III homologous repeats between the
constitutive fibronectin type III homologous repeats 5 and 6
(Spring et al ., 1989; Jones et al., 1989; Nies et al., 1991;
Siri et al ., 1991; Weller et al., 1991). Tenascin monomers
are assembled to hexamers by disulfide bridges at the amino-
terminal end and appear as hexabrachia by EM of rotary
shadowed molecules (Erickson and Inglesias, 1984). The
tenascin glycoproteins are expressed during formation of
various tissues and are absent or expressed only at low levels
in the adult (see Erickson and Bourdon, 1989, for review).
In the developing nervous system, tenascin is transiently ex-
pressed by immature astrocytes in boundaries of vibrissae-
related barrel fields in the somatosensory cortex during the
period of afferent fiber ingrowth (Steindler et al ., 1989a,b;
Crossin et al., 1989; Jhaveri et al., 1991). Furthermore,
these molecules have been suggested to play a crucial role
in regeneration in the peripheral nervous system, because the
expression of the molecules increased after lesioning the
sciatic nerve (Daniloff et al., 1989; Martini et al., 1990).
To appreciate the functional roles of tenascin in neuronal
migration and formation of neural connections, the behavior
of neural cells towards the purified molecule has been char-
acterized. Tenascin has been implicated in neural crest cell
migration (Tan et al., 1987; Bronner-Fraser, 1988; Mackie
et al., 1988 ; Stern et al., 1989) and promotion of neuroblas-
toma cell migration (Halfter et al., 1989). It inhibited adhe-
sion and spreading of hippocampal and mesencephalic neu-
rons (Lochter et al., 1991) or neural crest cells (Tan et al.,
1987; Halfter et al ., 1989). Furthermore, tenascin was found
to be a repulsive substrate for central nervous system neu-
rons (Faissner and Kruse, 1990) or neurites (Crossin et al.,
1990) and to inhibit neurite outgrowth when exposed to cells
in a soluble form (Lochter et al., 1991; Crossin et al., 1990).
However, tenascin has also been shown to mediate attach-
ment ofneurons to astrocyte surfaces in short-term cell bind-
ing assays (Kruse et al., 1985 ; Grumet et al., 1985) and to
promote neurite outgrowth when neurons were maintained
on tenascin/polyamine substrates (Lochter et al., 1991;
Wehrle and Chiquet, 1990) .
In view of the observations that a molecular domain be-
tween the tenth and eleventh fibronectin type III homologous
repeats of the mouse molecule was involved in neurite out-
growth promotion (Lochter et al., 1991), we askedthe ques-
tion which domains on the tenascin glycoprotein couldmedi-
ate cerebellar granule cell migration. Furthermore, it seemed
important to investigate whether these domains are the same
as or different from those involved in neurite extension. Here,
we report that t- .nascin influences migration and neurite out-
growth ofcerebellar granule cellsby different domains in the
fibronectin type III homologous repeats.
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Materials andMethods
Animals
For immunization, adult Lou x Sprague Dawley Fl hybrid female rats were
used. C57BL/6J mice were used for the migration assay. All other experi-
ments were carried out with NMRI mice.
Antibodies
mAbs to tenascin were prepared by immunization ofLou x Sprague Dawley
Fl hybrid female rats (2 to 3 moold) with glycopeptidase F-treated tenascin
from mouse brain. Deglycosylated tenascin (see Deglycosylation of N-linked
glycoconjugates) was chosen for immunization to minimize the generation
of antibodies against the strongly immunogenic L2/HNK1 carbohydrate
epitope (Kruse et al., 1984, 1985). Rats were immunized for the first time
with 50 hg tenascin in 1 nil PBS, pH 7.4, mixed with an equal volume of
complete Freunds adjuvant and threeor four times subsequently with 50 Ecg
tenascin in incomplete Freund's adjuvant at time intervals of 3 to 5 wk, all
subcutaneously. Animals with serum titersbetween 1:5,000and 1:10,000di-
lution asdetermined by ELISA (see Analytical procedures) were chosen for
fusion. Rats received two final intraperitoneal injections, each with 20 ttg
ofthe inununogen in PBS, 4 and 3 d before the fusion. Fusions were carried
out with the mouse myeloma clone X-Ag8-653 (Kearney et al., 1979) fol-
lowing established procedures (Lagenaur et al., 1980) with minor modifi-
cations (Faissner and Kruse, 1990). Hybridoma culture supernatants were
screened by ELISA using purified tenascin and further tested by Western
blot analysis. Out of 27 tenascin immunoreactive hybridoma supernatants,
three werefound by competition ELISA to recognizeepitopes different from
each other and from the epitopes recognized by the previously described
mAbs Jl/tnl and Jl/tn2 (Luchter et al., 1991) . Corresponding hybridoma
cells were then subcloned twice by the method oflimiting dilution (Lagenaur
et al., 1980) and designated Jl/tn3 (clone 630), Jl/tn4 (clone 633), and
Jl/tn5 (clone 635) .
The Ig subclass of the mAbs was determined by ELISA using affinity-
purified rabbit antibodies to rat Ig isotypes (kind gifts of Dr. H. Bazin,
Brussels). mAbs Jl/tn3 and Jl/tn4 could be assigned to the IgG2a subclass
and mAb Jl/tn5 to the IgGI subclass of rat Igs.
Larger quantities of mAbs were obtained by growing the hybridoma
clones in RPMI 1640 (Gibco Laboratories, Grand Island, NY) sup-
plemented with 1% (vol/vol) Nutridoma (Boehringer Mannheim Biochemi-
cals, Indianapolis, IN) . Culture supernatants were concentrated by ammo-
nium sulfate precipitation and dialyzed against PBS. By SDS-PAGE, the
antibodies revealed a purity of >95%.
The mouse mAb to bromodeoxyuridine (BrdU)1 was purchased from
Dianova (Hamburg, Germany) . Rabbit polyclonal antibodies to tenascin
from mouse brain (KAF 9(1)) have been described (Faissner and Kruse,
1990).
As secondary antibodies the following reagents were used: FITC-coupled
goat anti-mouse IgG and IgM antibodies (Dakopatts, Hamburg, Germany)
were used for indirectimmunofluorescence staining atadilution of 1:75. For
ELISA, HRP-coupled goat anti-rat IgG and IgM antibodies (Dianova,
Hamburg, Germany) were used at a dilution of 1:5,000. Western blot analy-
sis was performed using "3I-labeled sheep anti-rat IgG antibodies (5-20
EACi/ug, 250 nCi/ml; from Amersham International, Amersham, UK) at a
dilution of 1:400.
IsolationofExtracellularMatrix andNeural
Recognition Molecules
Tenascin was immunoaffinity purified from 1 to 15-d-old mouse brains or
supernatants from primary cultures of mouse embryonic fibroblasts using
mAb columns (Faissner and Kruse, 1990). In some cases, immunoaffinity-
purifiedtenascin preparations were subjected togel filtration on a Superosel2
(HR 10/50) columnusing fastperformance liquid chromatography (FPLC)
(Pharmacia/LKB, Piscataway, NJ) . In brief, immunoaffinity-purified tenas-
cin (1 .2-2.0 mg/4 nil in PBS) was loaded onto the column and separated
in PBS at 0.5-1 nil/minand afraction size of 1 nil. Fractions were analyzed
by ELISA and SDS-PAGE with subsequent silver staining. Fractions con-
taining tenascin were pooled. Immunoaffinity-purified and immunoaffinity
and subsequently FPLC-purifiedtenascin were used inall experiments with
identical results. Tenascin from chicken embryonic fibroblast supernatants
was a kind gift ofA. Kaplony (Zurich, Switzerland; Kaplony et al., 1991).
Tenascin from human embryonic fibroblasts supernatants (a kind gift of
1. Abbreviation used in this paper: BrdU, bromodeoxyuridine.
1476Dr. Wieser, Mainz, Germany) was isolated as described (Faissner and
Kruse, 1990).
The neural recognition molecules Ll and myelin-associated glycopro-
tein (MAG) were prepared as described (Rathjen and Schachner, 1984;
Poltorak et al., 1987). Crude membrane fractions from 9-d-old mouse
brains were prepared according to Fuss et al. (1991) .
Analytical Procedures
Protein determinations were carried out according to Bradford (1976).
SDS-PAGE was performed on slab gels (Laemmli, 1970). Linear gels were
stained with reducing silverions as described (Merril et al., 1982) . Western
blot analysis was performed after SDS-PAGE separation of proteins on
4-10% linear gradient slabgels, transfer to nitrocellulose filters, anddetec-
tion of proteins with mAbs and 'III-labeled sheep antibodies to rat IgG
(Faissner and Kruse, 1990).
For ELISA, wells of micro-test flexible assay plates (Falcon 3912; Bec-
ton Dickinson Labware, Oxnard, CA) were coated overnight at 4°C with
tenascin (100 O/well at 0.5 pg/ml 0.1 M NaHCO3). Wells were washed
with PBS, incubated for 1 h at 37°C with 0.1 M NaHCO3 containing 5 mg/
ml BSA, washed three times with PBS, and incubated for 3 h at 37°C with
hybridoma supernatants and mAbs. After three washes with PBS, wells
were incubated for 2 h at 37°C with HRP-coupled goat anti-rat IgG and
IgM polyclonal antibodies, washed three times, and developed with 1 mg/ml
ABTS (2,2'-azino-di-[3-ethylbenzthiazoline sulfonate (6)] ; Boehringer
Mannheim Biochemicals) in 100 mM Na-acetate, 50 mM Na-phosphate
(pH 4.2), and 0.01% H202. The optical density was measured at 405 nm
with an ELISA reader (Titertek Multiskan MKII, Flow).
To determine whether tenascin-recognizing hybridoma supernatants
competed with each otheror with thepreviously described mAbs Jl/tnl and
Jl/tn2 for bindingto tenascin, a competition ELISAwas carried out (Friguet
etal., 1983). Hybridoma supernatants or mAbs to becompared, were incu-
bated together with tenascin coated onto assay plates as described for the
ELISA. In parallel, wells were incubated individually with each antibody.
Hybridoma supernatants or mAbs indicating an increase in absorbance
when incubated together in comparison to being incubated individually
were taken to recognize different epitopes on the tenascin molecule. As a
positive control, mAbs Jl/ml and Jl/tn2, which recognize different epitopes,
were incubated together. As a negative control, a twofold amount of hybri-
doma supernatants or mAbs was incubated.
Deglycosylation ofN-linkedGlycoconjugates
Tenascin was treated with glycopeptidase F (Boehringer Mannheim Bio-
chemicals) as described (Faissner et al., 1988). The efficiency of deglyco-
sylation was determined by monitoring a shift to lower apparent molecular
weights by SDS-PAGE and subsequent silver staining.
Rotary Shadowingand EM
The binding sites of the mAbs Jl/tn3, Jl/tn4, and JI/tn5 were localized on
tenascin molecules as described (Vaughan etal., 1987; Lochter et al., 1991)
with minor modifications. Inbrief, tenascinand mAbs totenascin were dia-
lyzed against0.1 M ammoniumbicarbonateandmixedtoyield final concen-
trations of 40-80 pg/ml tenascin and 10-40 pg/ml mAbs. They were in-
cubated for 2 h at room temperature or overnight at 4°C. Samples were
mixed with an equal volume of glycerol and sprayed onto the surface of
freshly cleaved mica chips. The chips were dried in a freeze-fracture unit
(model BAF300; Balzers AG, Liechtenstein) under vacuum (lower than
10-7T) for at least 4 h and rotary shadowed with platinum/carbon at an an-
gle of 8° followed by a carbon backing film at 90°. Electron micrographs
were obtained with a Zeiss EM10C electron microscope. The curvilinear
lengths of the arms from the T-junction and the center of the distal knob
to the antibody binding sites were measured with a graphics tablet inter-
faced with the Kontron IBAS graphics system (Kontron Instruments,
Ziirich, Switzerland).
CellMigrationAssay
Organotypic explants of cerebellar folia from 10-d-old mice were main-
tained in culture by a procedure modified from a previously described
method (Lindner et al., 1983). Pieces of folia from the cerebellum were in-
cubated in a 25-nil Erlenmayer flask with 10 AM BrdU (Sigma Chemical
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Co., St. Louis, MO) at 70 rpm and 37°C for 90 min in 3 ml serum-free
defined culture medium (Fischer, 1982). The tissue pieces were washed
thoroughly with defined medium and five to seven pieces were incubated
in a 25-ml Erlenmayer flask or 2 h at 37°C in a C02 incubator in 3 nil
defined medium in the presence or absence of antibodies. The flasks were
then closed air-tight and maintained underconstant agitation at70 rpm and
37°C for 3 d. The tissue pieces were embedded in Tissue-Tek (Miles
Laboratories, Elkhart, Indiana) and fresh-frozen forsectioning inacryostat
(Jung 2700; Reichert & Jung, Nussloch, Germany) . 12-Am-thick sections
were cut in an orientation perpendicular to the length ofthe folia and used
for immunofluorescence staining with antibodies to BrdU.
Indirect immunofluorescence staining of BrdU was performed using a
procedure modified from Houck and Luken (1985). Sections were fixed for
30 min on ice with 0.5% paraformaldehyde in PBS. DNA was denatured in
4 N HCI containing 0.5% polyoxyethylene sorbitan monolaurate (Tween 20)
for 20min atroom temperature followedby neutralization with 0.1 M borate
buffer, pH 8.5. Sections were washed for 3 min with PBS and incubated with
the mAb to BrdU (10 pg/ml in PBS containing 0.5% Tween 20) for 30 min
at room temperature. After washing to PBS and blocking ofunspecific pro-
tein binding sites with 10% (vol/vol) horse serum and 1% (wt/vol) BSA in
PBS, sections were incubated for 20 min with FIX-coupled secondary an-
tibodies.
To allow detection of the different cerebellar layers, consecutive sections
ofeach folium were stained with hematoxylin and eosin. To this aim, sec-
tions were fixed with 4% ice-cold parafonnaldehyde in PBS for 5 min and
washed in PBS for 2 min beforestaining withhematoxylin (1 g hematoxylin,
0.2 g Na103, 50 g KAl(SO4)2, 50 g Chloralhydrate, 1 g citric acid in 1 liter
water) for 5 min and eosin (1:10[vol/vol] diluted with H2O; Riedel-deHaen,
Hannover, Germany) for another 5 min. Sections were briefly washed in wa-
ter and dehydrated by incubation in an ascending alcohol series.
The extent of cell migration was determined by counting the BrdU-
labeled cells in the external granular, molecular, and internal granular
layers. The dimensions ofthe counting fields taken for microscopic evalua-
tion were 280-400 Am x 280 Am (width, parallel to the pial surface x
length, perpendicular to the pial surface). At least six fields were analyzed
for each experiment and -300 labeled cells per field were counted in aver-
age in the presence or absence of antibodies. Setting the total number of
BrdU-labeled cells in each field as 100%, the percentage of cells in each
layer was then calculated. The mean values t SD of the percentages from
at leastthree independentexperiments for each experimentalcondition were
determined and compared for statistical significance by the Mann-Whitney
U test (Clauss and Ebner, 1977).
NeunteOutgrowth Assay
Glass coverslips (15 mm in diameter) were coated for 1-2 h at 37°C with
10 hg/ml poly-DL-ornithine (Sigma Chemical Co.) in 0.1 M borate buffer,
pH 8.5 (Collins, 1978), washed twice with distilled water, air dried, and
incubatedovernight at 37°C with PBS or PBS containing 75pg/nil tenascin,
sterilized by passage through 0.22-Am filters (Millex GV4; Millipore). Fi-
nally, coverslips were washed twice with PBS before cell plating.
Small cerebellar neurons from 6-8-d-old mice were purified by centrifu-
gation through a Percoll gradient (Keilhauer et al., 1985). Cells were
resuspended in culture medium (basal medium Eagle's (BME) containing
10% [vol/vol] horse serum) and plated at a density of 35,000 cells/350 JAI
culture medium per coverslip in wells of four-well plastic multidishes (A/S
Nunc, Raskilde, Denmark). Cultures were maintained for 48 h without
change of culture medium.
Whencultures were maintained in thepresence ofsoluble tenascinor an-
tibodies to tenascin, the protein solutions were dialyzed against BME and
sterilized by filtration (Millex GV4; Millipore) before addition to the cul-
tures 2 h after cell plating at final concentrations of 15, 60, or 250 pg/ml.
When antibodies were tested for their influence on soluble tenascin, anti-
bodies and soluble tenascin werepreincubatedtogether for 2 hat room tem-
perature and added to the cultures 2 h after cell plating at the final concen-
trations indicated for the individual components.
Morphometric measurements were carried out on cultures stained with
toluidine blue (Lochter et al., 1991). In each experiment, the longest and
the other, shorter neurites of 50 randomly selected, single neurons were
measured. The fraction of process-bearing neurons was determined by
counting at least 100 randomly selected, single neurons. The statistical
significance ofdifferences between experimental values was determined by
the Mann-Whitney U test (Clauss and Ebner, 1977) .
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ImmunochemicalAnalysis ofThree NovelmAbs to
TenascinfromMouse Brain
From five fusions, 27 hybridoma supernatants were found to
react with tenascin from mouse brain by ELISA . Out of
these, three hybridoma supernatants were selected, since
they did not interfere with each other or with the previously
generated mAbs Jl/tnl and Jl/tn2 (Faissner and Kruse, 1990)
in binding to tenascin as assayed by the competition ELISA
(not shown) . The resultant clones were designated Jl/tn3,
Jl/tn4, and Jl/tn5 .
In Western blot analysis, the three antibodies reacted with
two closely migrating, strong bands of 225 and 240 kD and
with two faint bands of 190 and 200 kD apparent molecular
masses in preparations of tenascin from mouse brain (Fig . 1,
lanes 1, 6, and 11), as described for Jl/tnl and Jl/tn2 (Faissner
and Kruse, 1990) . In preparations of tenascin from mouse
fibroblasts, the antibodies recognized two bands of 200 and
235 kD apparent molecular masses (Fig. 1, lanes 3, 8, and
13), as expected from previous observations (Aufderheide
and Ekblom, 1988 ; Weller et al ., 1991) . When tenascin from
mouse brain was deglycosylated using glycopeptidase F, the
binding of themAbs was not affected (Fig . l, lanes 2, 7, and
12), indicating that N-glycosidically linked carbohydrate
chains are not involved in the binding of themAbs . The three
mAbs did not react with the neural recognition molecules Ll
or MAG (Fig. 1, lanes 4, 5, 9, 10, 14, and 15) . When the
mAbs were subjected to Western blot analysis with extracts
of crude membrane fractions of 9-d-old mouse brain, the
same four immunoreactive bands with 240, 225, 200, and
190 kD apparent molecular masses were seen as with
purified tenascin frommouse brain (Fig . 1, lanes 16-18) . In
ELISA experiments the mAbs Jl/tn3-Jl/tn5 bound to tenas-
cin fromhuman fibroblasts, but not to tenascin from chicken
fibroblasts (not shown) . This was also described for themAb
Jl/tnl, but not for the mAb, Jl/tn2, which recognized tenas-
cin from both human and chicken fibroblasts (Faissner and
Kruse, 1990) .
The Journal of Cell Biology, Volume 116, 1992
Figure 1. Western blot analysis of
mAbs to tenascin . SDS-PAGE was
performed on 4-10% linear gradient
slab gels with 2 Fig tenascin from
mouse brain (lanes 1, 6, and 11), 2 leg
glycopeptidase F-treated tenascin
from mouse brain (lanes 2, 7, and 12),
2.5 ug tenascin from mouse fibroblasts
(lanes 3, 8, and 13), 3 Fig Ll (lanes 4,
9, and 14), 3 hg myelin-associated gly-
coprotein (lanes 5, 10, and 15), and
100 jig of a crude membrane fraction
from 9-d-old mouse brain (lanes 16-
18) . After transfer to nitrocellulose,
filters were incubated with 30 /,g/ml
mAb Jl/tn3 (lanes 1-5, 16), 25 ug/ml
ofmAb Jl/tn4 (lanes 6-10, 17), or 30
jig/nil ofmAb Jl/tn5 (lanes 11-15, 18),
and developed with 1251-labeled sheep
anti-rat IgG antibodies . Autoradio-
graphs ofthe Western blots are shown .
The positions ofmolecular mass marker
proteins are indicated at the left and
right margins in kilodaltons .
Localization ofAntibody Binding Siteson Tenascin
byEM
The binding sites for the mAbs Jl/tn3, Jl/tn4, and Jl/tn5 were
localized by EM of rotary shadowed tenascin molecules
from mouse brain . Tenascin molecules showed the typical
hexameric configuration, with the Tjunction at the amino
terminus in the center, the fine thread ofthe proximal portion
(EGF-like repeats), the thickened distal region (fibronectin
type III homologous repeats), and the distal knob (fibrinogen-
like domain) at the carboxy terminus (Fig . 2 a) . The distribu-
tion of the binding sites for the antibodies Jl/tn3, Jl/tn4, and
Jl/tn5 were measured as distances from both the Tjunction
and the distal end (Fig . 3) and are compiled in Table I . Only
those antibodies that were clearly visible alongside and
touching anarm were chosen for evaluation . The epitope for
the Jl/tn3 antibody was located 9 f 2 nm from the Tjunction
and 66 f 7 rim (n = 55) from the distal knob . The antibody
Jl/tn4 bound 41 t 5 run from the Tjunction and 35 t 5 nm
(n = 61) from the distal knob, whereas the distances of the
epitope of Jl/tn5 were 45 t 5 nun from the Tjunction and
29 t 4 nm (n = 66) from the distal knob . The three to four
peaks in the distributions ofthe distances measured between
antibody binding site and distal knob (Fig . 3, b, d, and f),
but not between antibody binding site and Tjunction (Fig .
3, a, c, and e), are most likely due to the presence ofdifferent
isoforms in the tenascin preparations (see Fig . 1, lanes 1, 6,
and 11), with molecules containing the differently spliced
fibronectin type III homologous repeats (see Lochter et al.,
1991) . Thus, the localization ofthe immunoreactive epitopes
can be assigned to the following domains . The mAbs Jl/tn4
and Jl/tn5 localize to the thickened distal portion of tenascin
in the region of the binding site for Jl/tnl (Lochter et al.,
1991), with Jl/tn4 binding between the third and fourth
fibronectin type III homologous repeats (Figs . 2 c, 3, c and
d, and 5) and Jl/tn5 binding between the fourth and fifth
fibronectin type 1111 homologous repeats (Figs. 2 d, 3, e and
f, and 5) . mAb Jl/tn3 reacts with the proximal thin portion
of the molecule between the third and fifth EGF-like repeats
(Figs. 2 b, 3, a and b, and 5) .
1478Figure 2 . Electron microscopic analysis ofmAb binding domains on tenascin from mouse brain after rotary shadowing . Electron micro-
graphs of rotary-shadowed tenascin from mouse brain (a) after preincubation with the mAbs Jl/tn3 (b), Jl/tn4 (c), and Jl/tn5 (d) are shown .
Each panel consists of four micrographs . Arrows in b-d indicate the binding sites of the mAbs . Bar in the last micrograph ofd represents
50 nm (for all micrographs) .
Fibronectin 7)tpeIIIHomologous Repeats Three to
Five ofTenascinAreInvolved in Cerebellar Granule
Cell Migration
To investigate the involvement of different domains of tenas-
cin in cerebellar granule cell migration, an in vitro assay sys-
tem was used in which the migration of neuronal precursor
cells can be quantitatively analyzed (Lindner et al., 1983) .
As a modification of this assay system, neuronal precursor
cells were pulse labeled before migration with BrdU instead
of 3H-thymidine. The BrdU-Iabeled granule cells were
visualized by indirect immunofluorescence and their migra-
tion distance was quantitatively analyzed by counting the rel-
ative frequency of BrdU-labeled cells in the different layers
ofthe cerebellar cortex which could be visualized by staining
adjacent sections with hematoxylin/eosin (Fig . 4) . After 3 d
Husmann et al . Functions ofTenascin in Fibronectin Type III Repeats
in culture in the absence of antibodies, 52 f 3 .7% of the
BrdU-Iabeled neuronal precursor cells migrated into the in-
ternal granular layer, while the external granular layer con-
tained 12 .7 f 2.3% and the molecular layer 34.9 f 3.8
of all BrdU-labeled cells (Table II ; see also Lindner et al.,
1983) . During these 3 d, the size of the external granular
layer decreased and the size of the molecular layer increased
in the absence of antibodies (Fig . 4, a and b) .
When explants were maintained for 3 d in vitro in the pres-
ence ofmAbs Jl/tn2 or Jl/tn3, a similar distribution ofBrdU-
labeled cells was seen (Table II ; compare Fig. 4 g to Fig . 4
f) . The IgG fraction of polyclonal antibodies to tenascin
from mouse brain revealed a significant inhibition of migra-
tion of BrdU-labeled cells (Table II) . The relative distribu-
tion of labeled cells after 3 d in vitro was 21.8 ± 4 .2% in
the external granular layer, 53 f 4.5% in the molecular layer
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Table L Morphometric Analysis ofmAb
Binding Sites on Tenascinfrom Mouse Brain by EM
ofRotary ShadowedMolecules
J1/tn3
J1/tn4
J1/tn5
100
distance, nm
￿
distance, nm
Figure 3. Histograms of the distribution of the antibody binding
siteson tenascin. The number ofdeterminations (ordinate) isplotted
against the curvilinear distance (abscissa, in nanometers) ofthe an-
tibody binding sites (Ab) on tenascin from mouse brain starting
from the Tjunction (a, c, and e) or from the center of the distal
knob (b, d, and f). Since the tenascin preparations contain a mix-
ture of isoforms (see Fig. 1, lanes 1, 6, and Il ), the values of the
distances encompassing the variable spliced region of the fibronec-
tin type III homologous repeats (b, d, andf) showed three to four
peaks in contrast to the values for the distances from the Tjunction
to the antibody binding sites (a, c, and e) where only one peak is
visible.
The distances (mean values t SD) from the Tjunction and the center of the
distal knob to the binding sites on tenascin ofthe different mAbs are given. The
total number of measurements for the different antibodies were n = 55 for
J1/tn3, n = 61 for J1/tn4, and n = 65 for J1/tn5 . Ab, antibody binding site.
' Results from Lochter et al. (1991) .
and only 25.2 f 4.5 % in the internal granular layer. The
mAbs Jl/tnl, Jl/tn4, and Jl/tn5 inhibited cerebellar granule
cell migration to a similar extent at antibody concentrations
of 0.2, 0.5, and 1 mg/ml (Table II; for Jl/tn4 at 0.2 mg/ml ;
see Fig. 4 h) . Only mAb Jt/tnl displayed reduced inhibitory
effects when assayed at a concentration of 0.2 mg/ml (Table
II) . The inhibitory effects of the mAbs J1/tnl, 4, and 5 and
polyclonal tenascin antibodies are not due to interference of
antibodies with granule cell proliferation or survival, since
the numbers of BrdU-incorporating cells determined under
control and experimental conditions were comparable. In
addition, the distribution of tenascin in the different layers
of the tissue slice after 3 d in culture is the same in the ab-
sence or presence of mAbs Jl/tn3 and Jl/tn4 as evaluated by
indirect immunofluorescence staining with a polyclonal anti-
body to tenascin (not shown) . In rare cases, the inhibitory
antibodies caused an increase in the size of the molecular
layer, but the effects were smaller than those reported in the
chicken (Chuong et al., 1987) and often hardly detectable.
Effects ofmAbs and Soluble Tenascin on Neunte
Outgrowth on Substrate-bound Tenascin
Since it had previously been shown that tenascin promotes
neurite outgrowth of embryonic mesencephalic and hip-
pocampal neurons through a domain recognizedby the mAb
Jl/tn2 (Lochter et al., 1991), we investigated whether the
same domain supported neurite outgrowth of small cerebel-
lar neurons, 90% of which are granule cells. These neurons
were obtained from 6-8-d-old mice, a developmental stage
when granule cell migration is reaching its peak. Neurons
were maintained in vitro for 48 h on tenascin from mouse
brain adsorbed to polyornithine (substrate-bound tenascin)
to allow attachment of cell bodies (Lochter et al ., 1991).
When plated onto polyornithine alone, only 11% of all small
cerebellar neurons developed neurites after 48 h of main-
tenance in vitro (Table III) . However, when these neurons
were maintained on substrate-bound tenascin, the percent-
age of process-bearing cells increased to -28% (Table III).
The percentage of cells with neurites was similar under all
conditions of this study: neurons grown in the presence of
mAbs to tenascin, soluble tenascin from mouse brain or
mouse fibroblasts, or soluble tenascin in the presence of
mAb Jl/tn5 (Table III) . The lengths of the longest neurites
of process-bearing cells on substrate-bound tenascin in-
creased by -50% when compared to neurite lengths of
process-bearing cells maintained on polyornithine alone,
whereas the lengths of the other, shorter neurites were in-
creased by -33% (Table III) . The number of neurites per
process-bearing cell was 1.4-1.7 in all experiments (not
shown) . Thus, the longest neurite contributed most to the to-
tal neurite length (N85%) (Table III). When the five mAbs
to tenascin (Jl/tnl to 5) were tested for theireffects on neurite
outgrowth of small cerebellar neurons on substrate-bound
tenascin, only J1/tn2 strongly inhibited neurite outgrowth at
60 1 g/ml (Table III; and see Lochter et al., 1991, for hip-
pocampal and mesencephalic neurons). Inhibition of neurite
outgrowth by mAb was the same for the longest and the
other, shorter neurites (Table III). None ofthe other antibod-
ies showed a significant reduction in neurite outgrowth under
the conditions of this study (Table III), even at concentra-
tions of 250 mg/ml (not shown).
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Antibody T-junction - Ab
Distance
Distal knob - Ab
nm nm
Jl/tnl' 47 t 3 23 t 3
Jl/tn2' 57 t 4 14 t 2
J1/tn3 9 t 2 66 t 7
J1/tn4 41 t 5 33 t 5
J 1/tn5 45 t 5 29 t 4When small cerebellar neurons were maintained on
substrate-bound tenascin and tenascin from mouse brain or
mouse fibroblasts was added at a concentration of 15 /Ag/ml
to the culturemedium (soluble tenascin), neurite outgrowth
was reduced to levels seen on polyornithine alone (Table III) .
This inhibitory effect of soluble tenascin could not be neu-
tralized by any of the mAbs to tenascin (Table III ; only
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Figure 4 . Influence of mono-
clonal tenascin antibodies on
cerebellar granule cell migra-
tion . The distribution ofBrdU
pulse-labeled cells in sections
of cerebellar folium explants
is shown by indirect immuno-
fluorescence (e-h) directly af-
terpulse labeling (e), after 3 d
in vitro in the absence of anti-
bodies (f), after 3 d in vitro in
the presence ofmAb Jl/tn3 at
1 mg/ml (g), or after 3 d in
vitro in the presence of mAb
Jl/tn4 at 0.2 mg/nil (h) . Ad-
jacent sections, stained with
hematoxylin/eosin correspond-
ing to the fluorescence images
e-h are shown in a-d, respec-
tively. EGL, external granular
layer ; ML, molecular layer ;
IGL, internal granular layer.
Bar, 50 lm .
shown for JI/tn5), even at concentrations of 250 /.g/ml (not
shown) . Furthermore, the percentage of process-bearing
cells and the number of neurites per cell were not signifi-
cantly different between cultures maintained in the presence
of soluble tenascin and cultures maintained in the combined
presence of soluble tenascin and mAb Jl/tn5 (Table III) as
described for hippocampal neurons (Luchter et al ., 1991) .
l4ß1Table II. Quantification of the Effects of mAbs to Tenascin on Cerebellar Granule Cell Migration
Discussion
The percentage of the relative distribution ofBrdU-labeled cells (mean value t SD) in the different cerebellar layers are shown directly after pulse labeling (t = 0)
or after 3 d in vitro in the absence (without antibody) or presence of antibodies as indicated. Numbers in brackets represent the number ofindependentexperiments
for each value. Significance levels for the values of the ML and the IGL (compared to the values in the absence of antibodies [without antibody]) were P 4 0.03
for the mAbs Jl/tnl, J1/tn4, Jl/tn5 and the polyclonal antibody and not significant for the mAbs J1/tn2 and Jl/tn3. EGL, external granular layer; ML, molecular
layer; IGL, internal granular layer.
An important first step towards identifying the functional do-
mains of tenascin glycoproteins depends on the availability
of mAbs directed against distinct epitopes of the molecule.
Several mAbs have been generated to tenascin from mouse,
chicken, and human (Bourdon et al., 1983 ; Chiquet and
Fambrough, 1984a,ó; Chiquet-Ehrismann et al., 1988;
Faissner and Kruse, 1990; Kaplony et al., 1991), but only
the mAbs Tn68 (Chiquet-Ehrismann et al., 1988) and Jl/tn2
(Faissner and Kruse, 1990; Lochter et al., 1991) identify two
distinct functional domains on the tenascin glycoproteins:
Tn68 recognizes a cell binding domain for fibroblasts which
localizes to fibronectin type III homologousrepeats 10 or 11
(corresponding to repeats 12 or 13 in mouse) in all isoforms
Table III. Quantification ofthe Influence ofmAbs to Tenascin and Soluble Tenascin on Neurite Outgrowth of Cultured
Cerebellar Granule Cells on Substrate-bound Tenascin
of chicken tenascin (Chiquet-Ehrismann et al., 1986; Spring
et al ., 1989) and Jl/tn2 recognizes a neurite outgrowth
promoting domain for mesencephalic and hippocampal neu-
rons which localizes to a short region of transition between
fibronectin type III homologous repeats 10 and 11 of mouse
tenascin (corresponding to repeats 8 or 9 in chicken). This
is not conserved in the chicken, since Jl/tn2 reacts with all
known isoforms of mouse tenascin (Faissner and Kruse,
1990), but does not recognize the 190-kD isoform ofchicken
tenascin (L. Vaughan, unpublished observations).
To extend the repertoire of mAbs directed against func-
tionally important molecular domains, three novel mAbs,
Jl/tn3, Jl/tn4, and Jl/tn5, have been generated against mouse
tenascin. The immunoreactive domains, determined by elec-
tron microscopic analysis ofthe antibody binding siteson ro-
Summed neurite lengths from 50 neurons of
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The summed neurite length (mean values f SD)of 50 randomly selected neurite-bearing cells from one coverslip are shown for the longest neurite and for the
other, shorter neurites of these cells. The fraction of neurite bearing cells per coverslip (mean value ± SD) was determined by counting at least 100 randomly
selected, single cells. Concentrations ofadditives in the experiments were 60 ug/ml for each antibody and 15 gg/ml for soluble tenascin from mouse brain (sTN)
or from mouse fibroblasts (sTN[mes]). Significance levels (compared to neurons cultured on substrate-bound tenascin [bTN]) are indicated by the following sym-
bols: *, 0.001 < P 4 . 0.01 ; t, 0.01 < P < 0.05. Numbers in parentheses represent the number of independent experiments for each culture condition.
Longest neurite Other neurites
Fraction of process
bearing cells
,um #m
PORN (10) 2,370 ± 281* 431 ± 80* 11 ± 2.3*
bTN (10) 3,692 ± 357 574 ± 112 28 ± 5.1
bTN+JI/tnl (3) 3,699 ± 60 600 ± 125 30 ± 2.9
bTN+JI/tn2 (5) 2,380 ± 206* 442 ± lolt 23 ± 4.6
bTN+Jl/tn3 (6) 3,489 ± 352 620 ± 184 24 ± 3.6
bTN+Jl/tn4 (5) 3,851 ± 461 579 ± 189 27 ± 4.1
bTN+J1/tn5 (4) 3,730 ± 322 523 ± 235 28 ± 2.4
bTN+sTN (7) 2,715 ± 93* 483 ± 104t 25 ± 6.2
bTN+sTN(mes) (3) 2,475 ± 287* 480 ± 159 26 ± 5.2
bTN+sTN+JI/tn5 (3) 2,620 ± 1l5* 512 ± 61 26 ± 3.5
Antibody Concentration
mglml
in EGL
% Cells
in ML in IGL
t=0 93 .7±2.9 2 .2±2.2 4.2±2.8 (4)
Without antibody 12 .7 ± 2.3 34 .9 ± 3.8 52.4 ± 3 .7 (4)
J1/tn2 1 .0 12 .5 ± 3.5 37 .5 ± 2.9 50.2 ± 4.1 (3)
J 1/tn3 1 .0 13 .2 ± 2.3 40.1 ± 4.4 46.8 ± 5.4 (4)
Polyclonal antibody 1 .0 21.8 ± 4.2 53.0 ± 4.5 25 .2 ± 4.5 (3)
J1/tnl 1 .0 22 .5 ± 3.4 51 .6 ± 3.6 25 .9 ± 4.8 (3)
J1/tnl 0.5 17 .3 ± 4.4 52 .4 ± 2.7 30.3 ± 3.9 (3)
J1/tn1 0.2 16.7 ± 2.6 43 .0 ± 4.1 40.4 ± 4.3 (3)
JI/tn4 1 .0 15.8 ± 5 .2 52 .8 ± 3.6 31 .0 ± 4.7 (3)
J1/tn4 0.5 18.3 ± 3 .7 54 .4 ± 3.4 27 .4 ± 2.4 (3)
J1/tn4 0.2 19 .3 ± 2.8 52 .5 ± 2.8 28.0 ± 4.7 (3)
J1/tn5 1 .0 17 .6 ± 3.9 54.8 ± 4.2 27.5 ± 5.0 (3)
J1/tn5 0.5 17 .8 ± 4.1 55 .5 ± 4.1 26.8 ± 5.0 (3)
J1/tn5 0.2 18 .2 ± 5.5 53 .5 ± 3.3 28.4 ± 6.7 (3)J1/tn4 Jt/tnt
￿
Figure 5. Schematic represen-
J1/tn3
￿
J1r-
/tn5
￿
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￿
talion ofthe topography ofthe
mAb binding sites on tenascin
as deduced from EM. This
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structural model for tenascin
frommouse fibroblasts is based
on sequence data by Weller et
EGF-like repeats
￿
fibronectin type III repeats
￿
fibrinogen-like
￿
al. (1991). The NHz terminus domain
￿
is indicated at the left and the
COOH terminus at the right. The circle segment at the NHZ terminus represents the sequence contributing to the central globule. The
14.5 contiguous EGF-like repeats (small rectangles) represent the thin proximal and the 13 contiguous fibronectin type III homologous
repeats (large rectangles) the thick distal part of the tenascin molecule. The alternatively spliced fibronectin type III homologous repeats
6-10 are indicated as large, hatched rectangles. The circle at the carboxy terminus represents the sequence with homologies to 0- and
-y-fibrinogen. The binding site for the monoclonal antibody Jl/tn3 localizes between the third and fifth EGF-like repeats. The binding site
for monoclonal antibodies Jl/tnl (taken from Lochter et al ., 1991), Jl/tn4, and Jl/tn5 localize to the region between the third and fifth
fibronectin type III homologous repeats. The binding site for the mAb Jl/ tn2 (taken from Lochter et al., 1991) localizes to fibronectin
type III repeat eleven.
tary shadowed molecules, could be assigned to the EGF-like
repeats 3-5 for Jl/tn3, to fibronectin type III homologous
repeats 3 or 4 for Jl/tn4 and to fibronectin type III homolo-
gous repeats 4 or 5 for Jl/tn5 (Fig. 5). These domains do not
belong, like the previously described mAbs Jl/tnl and Jl/tn2
(Lochter et al., 1991) to the alternatively spliced parts of the
molecule, since mAbs Jl/tnl to 5 react with all tenascin iso-
forms known in the mouse by Western blot analysis. The epi-
topes involved are resistant to glycopeptidase F treatment,
thus, either localizing these to the protein backbone or to
O-glycosidically linked carbohydrates.
By the use of this panel of mAbs to mouse tenascin, we
could show that migration and neurite outgrowth of cerebel-
lar granule cells is influenced by different domains in the
fibronectin type III homologous repeats of tenascin: migra-
tion is influenced by the third to fifth fibronectin type III ho-
mologous repeats, while promotion of neurite outgrowth,
not only of cerebellar granule cells, but also of mesen-
cephalic and hippocampal neurons (Lochter et al., 1991),
depends on a domain of the eleventh fibronectin type III ho-
mologous repeat. The specificity ofthe assignment ofthe do-
main for migration is underscored by previous observations
on the effects of polyclonal antibodies raised against Jí-
160/180, a tenascin-related extracellular matrix glycoprotein
of oligodendrocytes (Pesheva et al ., 1989) . These antibodies
show some crossreactivity with the mouse tenascin isoforms
(Kruse etal ., 1985 ; Faissner et al ., 1988), butdid not reduce
neuron migration in the cerebellar explant system (Antoni-
cek et al., 1987).
The observation that migration and neurite outgrowth by
cerebellar granule cells depend on different domains on the
tenascin molecule begs the question as to the functional in-
terrelationships and distinctions between the two phenomena.
Granule cell migration is the result of a complex series of
individual events among which neurite extension is an out-
standing feature. Neuronal precursor cells in the external
granular layer, the germinal zone ofthe early postnatal cere-
bellar cortex, withdraw from the cell cycle and associate
with the radial Bergmann glial fibers (Rakic, 1971; Altman,
1982). The postmitotic granule neurons then extend two ax-
onal processes alongside other axons of granule cells that
have preceded them to form the dense fascicle bundles of
parallel fibers in the molecular layer. The granule cell bod-
ies, after residing in the premigratory zone for -28 h, then
transverse the molecular layer in close cell surface contact
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with Bergmann glial processes from the external to the inter-
nal granular layer within a time period of4 h (Fujita, 1969) .
This translocation is guided by the leading process of the
granule cell which remains in close apposition to the radial
glial process throughout its course ofmigration until it leaves
the glial process to take up its final position in the internal
granular layer (Rakic, 1990; Sitt and Hatten, 1990). Thus,
the phenomenon of neurite outgrowth is an integral part of
granule cell migration, first as extension of axons and then
as elaboration of the leading process.
It is tempting to allocate a functional role for tenascin to
a distinct cellular event in granule cell migration on the basis
ofour knowledge about the molecule's expression and distri-
bution during the period of granule cell migration at early
postnatal stages. Tenascin is synthesized by and detectable
at the surface of Bergmann glial cells in all cerebellar layers
(Bartsch et al., 1991) . However, although granule cells do
not synthesize the molecule, their axonal surfaces, but not
their cell bodies show highest levels of tenascin im-
munoreactivity at times coincident with neurite outgrowth.
Tenascin has not been detected at the contact sites between
Bergmann glial processes and migrating granule cell bodies,
while it is amply present at the sites ofcontact between paral-
lel fibers and migrating granule cells. Thus, the site of action
of tenascin in granule cell migration is difficult to deduce
from its cellular localization. Since tenascin does not appear
to promote granule cell migration by allowing neurite exten-
sion to occur, its function is likely to be otherwise. It cannot
be as simple as enhancing the motility of cell bodies as it has
been observed for neural crest cells on substrate-bound
tenascin (Halfter et al., 1989), since tenascin is not present
at the site ofcontact between the migrating granule cell body
and Bergmann glial process, where such interactions could
be assumed to be most effective. However, tenascin could be
instrumental at the sites of contactbetween the premigratory
or migratory granule cell body with the tenascin-positive
parallel fibers. Also, tenascin may be active in the detach-
ment of the leading process from the Bergmann glial fiber
when entering the internal granular layer.
The distribution of granule cell bodies in the different
layers of the cerebellar cortex was determined under influ-
ence of the migration inhibitory antibodies, to assess at
which migratory stage the functional impact of tenascin
could be crucial. As reported previously for antibodies to
cytotactin (Chuong et al., 1987), granule cell bodies accu-
1483mulated throughout the molecular layer, thus opening the
possibility that translocation of granule cell bodies on Berg-
mann glial processes may depend on tenascin. It is interest-
ing in this context to compare the sitesof inhibition by other
agents. Antibodiesto the astrocyte-derived extracellular ma-
trix glycoprotein thrombospondin or a neural lectin and one
of its ligands abolish granule cell migration at the outset,
possibly by inhibition of attachment of granule cell bodies
to Bergmann glial processes, such that granule cells do not
leave the external granular layer (O'Shea et al ., 1990; Leh-
man et al., 1990) . The neural recognition molecule Ll in the
mouse and its related molecule in the chicken, Ng-CAM,
have both been implicated in early phases of granule cell
migration (Lindner et al., 1983, 1986 ; Chuong et al., 1987) .
Since Ll has not been detected at sites of contact between
migrating granule cell bodies and Bergmann glial processes
(Persohn and Schachner, 1987), since Ll does not promote
recognition between granule cellsand mature, glial fibrillary
acidic protein-positive cerebellar astrocytes (Keilhauer et
al., 1985), and since Ll plays an important role in axon fas-
ciculation (Fischer et al., 1986; Rathjen, 1988, for review),
we have suggested that disturbance of fasciculation of gran-
ulecell axons leads to a reduced migratory activity ofgranule
cells. The adhesion molecule on glia, the tissue plasminogen-
activator/plasmin system, and a protease inhibitor of the
nexin family have also been implicated in granule cell migra-
tion, possibly at the stage of entrance of granule cells into
the molecular layer (Moonen et al., 1982; Lindner et al.,
1986; Antonicek et al., 1987). Thus, granule cell migration
is a composite of distinct cellular interactions which can be
perturbed at different sites and times during the migration
process and implicates several recognition molecules. Tenas-
cin appears to be the latest acting of all molecular compo-
nents so far recognized to mediate granule cell migration.
Sincetenascin does not mediate granule cell migration by
the same molecular domain as that which promotes neurite
extension, the question is, which of the multifaceted func-
tional properties of the molecule may be compatible with its
role in granule cell migration. The cell binding domain for
fibroblasts recognized by mAb Tn68 (Chiquet-Ehrismann et
al., 1988; Spring et al ., 1989)may be a prerequisite for any
tenascin-mediated cell interaction (Lotz et al ., 1989), yet is
not sufficientfor cell migration which depends on the Jl/tnl,
4, and 5 domains. Whether these domains would be involved
in the stimulation of cell motility (Halfter et al., 1989) is
presently unknown. It is also not known to what extent the
inhibitory or repulsive properties of tenascin are involved in
granule cell migration. Under certain circumstances, tenas-
cin interferes with cell-to-substrate adhesion of most cell
types investigated so far, including neural crest cells (Tan et
al., 1987; Mackie et al., 1988; Epperlein et al., 1988; Halfter
et al ., 1989) and mesodermal cells from gastrula stage em-
bryos (Riouet al., 1990). Inhibitory effects can also be seen,
when neurons are confronted with a choice of a more favor-
able and less favorable substrate, where cell body attachment
to (Faissner and Kruse, 1990) or growth cone movement into
the less favorable substrate tenascin (Taylor, J., P Pesheva,
and M . Schachner, manuscript submitted for publication) is
inhibited. Such inhibitory properties have been suggested
to play a role in the stabilization of barrel field boundaries
in the developing somatosensory cortex (Steindler et al.,
1990a,b; Crossin et al., 1990; Jhaveri et al., 1991) and patch-
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matrix compartments in the developing striatum (O'Brien et
al., 1991). It is conceivable that tenascin, by virtue of its cell
repulsive properties, participates in the de-adhesion of neu-
rons from radial glial processes at the transition from the
molecular to the internal granular layer, thus slowing down
the migrating successor neurons on the same guidepost.
In summary, our study defines a new functional domain of
tenascin localizing between the third and fifth fibronectin
type III homologous repeats, which is distinct from the neu-
rite outgrowth promoting domain, the cell binding domain,
and the presumed inhibitory domain (Chiquet-Ehrismann et
al ., 1986; Spring et al ., 1989; Lochter et al ., 1991) . It is con-
ceivable that these distinct domains employ distinct receptor
systems by which they control different cellular signalling
systems, as shown, for example, for the neural recognition
molecules Ll and N-CAM (Schuch et al., 1989; Atashi
et al., 1991; Von Bohlen and Halbach, J. Taylor, and M.
Schachner, manuscript submitted for publication). Identifi-
cation of the receptors involved and characterization of the
transduction mechanisms in complex cellular assemblies
(Steindler et al., 1989a,b; 1990) are major challenges for fu-
ture investigations.
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